Kiran Mazumdar-Shaw insider trades

Open-market stock purchases and sales by Kiran Mazumdar-Shaw, Director at Bicara Therapeutics Inc, from SEC Form 4 filings since Sep 12, 2024.

Recent trades

DateStockTradeValue
Jun 9, 2026BCAX Bicara Therapeutics IncBought (not open market)—

Companies traded

  • BCAX Bicara Therapeutics Inc: other filings, last Jun 9, 2026

Get free alerts when Kiran Mazumdar-Shaw files a new trade →